Tetherex Pharmaceuticals IPO

Developer of drugs for the treatment of inflammatory and thrombotic diseases. The company's treatment program is built around an antibody called SelK2 directed against the cell adhesion molecule P-Selectin Glycoprotein Ligand-1 (PSGL-1).

Register for Details

For more details on financing and valuation for Tetherex Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Tetherex Pharmaceuticals

Forge green plus iconForge green minus icon

What is Tetherex Pharmaceuticals's IPO price?

The IPO price for Tetherex Pharmaceuticals will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Tetherex Pharmaceuticals?

Tetherex Pharmaceuticals is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Tetherex Pharmaceuticals share pre-IPO?

If you own Tetherex Pharmaceuticals pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Tetherex Pharmaceuticals a publicly traded company?

Tetherex Pharmaceuticals is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Tetherex Pharmaceuticals's funding to date?

Tetherex Pharmaceuticals has raised $68.65MM to date.
Forge green plus iconForge green minus icon

When was Tetherex Pharmaceuticals founded?

Tetherex Pharmaceuticals was founded in 2002.

Tetherex Pharmaceuticals Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
4/18/2018 Series B $63.95MM raised $XXX.XX $XXX.XX
2/9/2015 Series A $4.69MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Nov 15, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.